Kewaunee Scientific (KEQU) Common Equity (2011 - 2026)

Kewaunee Scientific's Common Equity history runs 16 years deep, the most recent figure standing at $74.7 million for Q2 2026.

• On a quarterly basis, Common Equity rose 15.92% year-over-year to $74.7 million in Q2 2026; TTM through Apr 2026 was $74.7 million, a 15.92% increase from a year earlier, with the FY2026 full-year figure at $74.7 million, up 15.92% from the prior year.
• Common Equity improved to $74.7 million in Q2 2026 per KEQU's latest filing, from $70.7 million in the prior quarter.
• Across five years, Common Equity topped out at $74.7 million in Q2 2026 and bottomed at $34.4 million in Q4 2022.
• The 5-year median for Common Equity is $49.4 million (2024), against an average of $50.9 million.
• Across the five-year window, Common Equity decreased 13.45% in 2022 and soared 46.38% in 2024, its largest moves.
• Year by year, Common Equity stood at $34.4 million in 2022, then rose by 22.4% to $42.1 million in 2023, then surged by 40.89% to $59.3 million in 2024, then rose by 17.74% to $69.9 million in 2025, then increased by 6.97% to $74.7 million in 2026.
• Per Business Quant, the three latest KEQU Common Equity figures stand at $74.7 million (Q2 2026), $70.7 million (Q1 2026), and $69.9 million (Q4 2025).